NVTA - Invitae Corp - SEC Form 4 Insider Trading Screener
80 results - 
- 
- 
- 
- 
- 
- - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020-11-24 | NVTA | Werner Robert F. | Chief Accounting Officer | S - Sale | $48.92 | -2,427 | 58,398 | -4% | -$118,718 | ||||||
| D | 2020-11-20 | NVTA | George Sean E | Pres, CEO | S - Sale+OE | $47.98 | -8,683 | 634,693 | -1% | -$416,606 | |||||
2020-11-18 | NVTA | Guyer Shelly D | CFO | S - Sale | $46.75 | -3,000 | 224,520 | -1% | -$140,264 | ||||||
2020-11-17 | NVTA | Brida Thomas | GC | S - Sale | $46.01 | -5,000 | 207,876 | -2% | -$230,052 | ||||||
| D | 2020-11-16 | NVTA | Aguiar Eric | Dir | S - Sale+OE | $46.52 | -30,000 | 0 | -100% | -$1,395,711 | |||||
2020-11-13 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $48.00 | -1,000 | 237,352 | 0% | -$48,000 | ||||||
2020-10-13 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $51.36 | -1,000 | 238,352 | 0% | -$51,360 | ||||||
2020-09-15 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $35.51 | -1,000 | 239,352 | 0% | -$35,510 | ||||||
2020-09-10 | NVTA | Werner Robert F. | Chief Accounting Officer | S - Sale | $33.87 | -246 | 30,334 | -1% | -$8,331 | ||||||
2020-09-10 | NVTA | George Sean E | Pres, CEO | S - Sale | $33.87 | -742 | 638,376 | 0% | -$25,129 | ||||||
2020-09-10 | NVTA | Guyer Shelly D | CFO | S - Sale | $33.87 | -631 | 227,520 | 0% | -$21,370 | ||||||
2020-09-10 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $33.87 | -631 | 240,352 | 0% | -$21,370 | ||||||
2020-09-10 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $33.56 | -23,175 | 208,661 | -10% | -$777,812 | ||||||
2020-09-10 | NVTA | Brida Thomas | GC | S - Sale | $33.87 | -633 | 212,252 | 0% | -$21,438 | ||||||
2020-08-19 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $32.10 | -21,345 | 239,730 | -8% | -$685,102 | ||||||
2020-08-19 | NVTA | Werner Robert F. | Chief Accounting Officer | S - Sale | $32.10 | -1,740 | 30,037 | -5% | -$55,847 | ||||||
2020-08-19 | NVTA | Guyer Shelly D | CFO | S - Sale | $32.10 | -18,956 | 226,898 | -8% | -$608,417 | ||||||
2020-08-19 | NVTA | Brida Thomas | GC | S - Sale | $32.10 | -12,416 | 211,628 | -6% | -$398,508 | ||||||
2020-08-19 | NVTA | George Sean E | Pres, CEO | S - Sale | $32.10 | -15,473 | 637,643 | -2% | -$496,629 | ||||||
2020-08-19 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $32.10 | -19,049 | 230,730 | -8% | -$611,399 | ||||||
2020-08-12 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $29.31 | -1,000 | 261,075 | 0% | -$29,310 | ||||||
2020-07-17 | NVTA | Guyer Shelly D | CFO | S - Sale | $33.16 | -12,000 | 245,854 | -5% | -$397,927 | ||||||
2020-07-14 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $32.50 | -1,000 | 262,075 | 0% | -$32,500 | ||||||
| D | 2020-07-15 | NVTA | Aguiar Eric | Dir | S - Sale+OE | $33.99 | -10,000 | 0 | -100% | -$339,853 | |||||
| D | 2020-07-13 | NVTA | Bendekgey E Lee | COO | S - Sale+OE | $34.16 | -27,500 | 218,311 | -11% | -$939,509 | |||||
2020-07-09 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $34.15 | -29,783 | 249,779 | -11% | -$1,017,112 | ||||||
| D | 2020-06-12 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale+OE | $16.34 | -1,000 | 263,075 | 0% | -$16,340 | |||||
| M | 2020-05-20 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $17.13 | -26,757 | 200,412 | -12% | -$458,397 | |||||
2020-05-20 | NVTA | Guyer Shelly D | CFO | S - Sale | $16.70 | -5,250 | 198,704 | -3% | -$87,679 | ||||||
2020-05-20 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $16.70 | -6,177 | 204,925 | -3% | -$103,161 | ||||||
2020-05-20 | NVTA | Bendekgey E Lee | COO | S - Sale | $16.70 | -9,348 | 159,161 | -6% | -$156,119 | ||||||
2020-05-20 | NVTA | Brida Thomas | GC | S - Sale | $16.70 | -2,060 | 164,894 | -1% | -$34,404 | ||||||
2020-05-20 | NVTA | George Sean E | Pres, CEO | S - Sale | $16.70 | -25,500 | 526,566 | -5% | -$425,870 | ||||||
2020-05-12 | NVTA | Bendekgey E Lee | COO | S - Sale | $18.11 | -18,665 | 168,509 | -10% | -$338,079 | ||||||
2020-05-13 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $17.56 | -1,000 | 211,102 | 0% | -$17,560 | ||||||
2020-04-13 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $12.80 | -1,000 | 212,102 | 0% | -$12,803 | ||||||
| M | 2020-03-13 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $11.78 | -11,684 | 213,102 | -5% | -$137,608 | |||||
2020-03-16 | NVTA | Bendekgey E Lee | COO | S - Sale | $11.79 | -11,056 | 187,174 | -6% | -$130,350 | ||||||
2020-03-16 | NVTA | Brida Thomas | GC | S - Sale | $11.79 | -9,226 | 165,868 | -5% | -$108,775 | ||||||
2020-03-16 | NVTA | George Sean E | Pres, CEO | S - Sale | $11.79 | -11,655 | 552,066 | -2% | -$137,412 | ||||||
2020-03-16 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $11.79 | -10,684 | 227,169 | -4% | -$125,964 | ||||||
2020-03-16 | NVTA | Guyer Shelly D | CFO | S - Sale | $11.79 | -10,684 | 203,954 | -5% | -$125,964 | ||||||
2020-02-27 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $20.43 | -1,000 | 133,053 | -1% | -$20,435 | ||||||
| D | 2020-02-26 | NVTA | Bendekgey E Lee | COO | S - Sale+OE | $20.76 | -119,789 | 106,497 | -53% | -$2,487,087 | |||||
2020-01-14 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $18.14 | -1,000 | 134,053 | -1% | -$18,137 | ||||||
2019-12-13 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $17.08 | -1,000 | 135,053 | -1% | -$17,082 | ||||||
2019-11-14 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $17.46 | -3,788 | 136,053 | -3% | -$66,123 | ||||||
2019-09-17 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $21.40 | -3,788 | 139,841 | -3% | -$81,081 | ||||||
2019-08-26 | NVTA | Scott Randal W | Exec COB | S - Sale | $24.59 | -40,000 | 3,450,669 | -1% | -$983,405 | ||||||
2019-08-22 | NVTA | Crouse Geoffrey | Dir | S - Sale | $25.68 | -5,000 | 29,259 | -15% | -$128,410 | ||||||
2019-08-19 | NVTA | Guyer Shelly D | CFO | S - Sale | $25.38 | -24,447 | 122,905 | -17% | -$620,574 | ||||||
2019-08-19 | NVTA | Bendekgey E Lee | COO | S - Sale | $25.29 | -21,265 | 140,323 | -13% | -$537,883 | ||||||
2019-08-19 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $25.29 | -20,447 | 146,120 | -12% | -$517,193 | ||||||
2019-08-19 | NVTA | George Sean E | Pres, CEO | S - Sale | $25.29 | -16,358 | 463,649 | -3% | -$413,764 | ||||||
2019-08-19 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $25.29 | -22,900 | 143,629 | -14% | -$579,239 | ||||||
2019-08-19 | NVTA | Brida Thomas | GC | S - Sale | $25.29 | -13,663 | 95,870 | -12% | -$345,596 | ||||||
2019-07-15 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $22.49 | -3,789 | 170,318 | -2% | -$85,231 | ||||||
2019-06-13 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $19.36 | -3,789 | 174,107 | -2% | -$73,356 | ||||||
2019-05-28 | NVTA | Scott Randal W | Exec COB | S - Sale | $17.60 | -30,000 | 3,490,669 | -1% | -$528,027 | ||||||
2019-05-20 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $18.21 | -6,474 | 177,896 | -4% | -$117,892 | ||||||
2019-05-20 | NVTA | Brida Thomas | GC | S - Sale | $18.21 | -2,146 | 109,533 | -2% | -$39,079 | ||||||
2019-05-20 | NVTA | Bendekgey E Lee | COO | S - Sale | $18.21 | -6,851 | 161,588 | -4% | -$124,757 | ||||||
2019-05-20 | NVTA | George Sean E | Pres, CEO | S - Sale | $18.21 | -24,282 | 480,007 | -5% | -$442,175 | ||||||
2019-05-20 | NVTA | Guyer Shelly D | CFO | S - Sale | $18.03 | -9,513 | 147,352 | -6% | -$171,539 | ||||||
2019-05-20 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $18.21 | -7,202 | 166,567 | -4% | -$131,148 | ||||||
2019-05-15 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $18.36 | -1,000 | 184,370 | -1% | -$18,360 | ||||||
2019-05-14 | NVTA | Bendekgey E Lee | COO | S - Sale | $18.78 | -4,657 | 168,439 | -3% | -$87,439 | ||||||
2019-04-16 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $25.23 | -1,000 | 185,370 | -1% | -$25,230 | ||||||
2019-03-15 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $23.49 | -1,000 | 186,370 | -1% | -$23,490 | ||||||
2019-02-27 | NVTA | Guyer Shelly D | CFO | S - Sale | $20.00 | -4,000 | 156,865 | -2% | -$80,018 | ||||||
2019-02-27 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $19.61 | -1,000 | 187,370 | -1% | -$19,610 | ||||||
2019-02-27 | NVTA | Dumond Patty | See Remarks | S - Sale | $19.71 | -5,000 | 88,811 | -5% | -$98,540 | ||||||
2019-02-26 | NVTA | Bendekgey E Lee | COO | S - Sale | $19.62 | -4,650 | 173,096 | -3% | -$91,213 | ||||||
2019-02-25 | NVTA | Scott Randal W | Exec COB | S - Sale | $19.10 | -30,000 | 3,520,669 | -1% | -$572,997 | ||||||
2019-01-16 | NVTA | Dumond Patty | See Remarks | S - Sale | $15.00 | -3,000 | 93,811 | -3% | -$45,000 | ||||||
2019-01-16 | NVTA | Guyer Shelly D | CFO | S - Sale | $14.49 | -4,000 | 160,865 | -2% | -$57,968 | ||||||
2019-01-15 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $13.59 | -1,000 | 188,370 | -1% | -$13,590 | ||||||
2019-01-10 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $14.01 | -5,222 | 163,769 | -3% | -$73,153 | ||||||
| A | 2018-11-12 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $13.11 | -10,444 | 168,991 | -6% | -$136,964 | |||||
2018-12-17 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $11.44 | -1,000 | 189,370 | -1% | -$11,437 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |